Project Grant HT94252310530
Award Date 8/1/23
Completion Date 7/31/26
Dollars Obligated $691K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Urbana, IL 61801, USA
Similar Awards
- The University of Illinois was awarded a $719,550 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. The grant, with an April 1, 2024 award date and March 31, 2027 completion date, will support research on the TRKA-MLK3 axis as an actionable target in triple-negative breast cancer. The project aims to advance scientific understanding and develop new treatments related to this specific type of breast cancer, which is a key...
- The University of Illinois has been awarded a $1,235,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to leverage data science methods to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The 3-year grant, awarded on August 15, 2025, will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public. The research aims...
- The Defense Health Agency awarded a $1,398,689 Project Grant to the University of Illinois under the Military Medical Research and Development program (CFDA 12.420) to support research on "Pharmacologic Downregulation of SOX2 to Enhance Efficacy of Anti-AR Therapies in Prostate Cancer". The project aims to investigate methods for improving the effectiveness of anti-androgen therapies for prostate cancer through modulating the SOX2 protein. The award will fund this 3-year research...
- The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
- The University of Illinois was awarded a $1,499,728 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate a novel approach to reverse volumetric muscle loss following transfemoral amputations, with the goal of improving mobility and function. The research aims to transform health care for service members and the American public through innovative biomedical...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is providing $1,465,443 to the University of Illinois to support research on "The Promise of Epigenetic Therapy for Refractory Testicular Germ Cell Tumors". The award period runs from September 1, 2025 to August 31, 2028. As a leading public research institution, the University of Illinois has extensive experience in executing federal grants and...
- This Project Grant award of $639,600.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research by the University of Illinois to investigate the role of osteopontin-high macrophages in protecting against metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma. The research project will be conducted over a period of approximately 3 years, from August 1, 2024 to July 31, 2027. The University of...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,602,572.00 in funding to the University of Illinois to support research on the role of the novel hexokinase HKDC1 in hepatocellular carcinoma. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Illinois, a major public research university in Chicago, will conduct innovative scientific studies to advance...
- The University of Illinois was awarded a $798,912 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to investigate how PFAS (per- and polyfluoroalkyl substances) exposures can reprogram prostate stem cells and drive carcinogenesis and cancer progression. The 3-year project, running from July 1, 2023 to June 30, 2026, will advance scientific understanding of how environmental PFAS exposures may...